ExoDx Prostate Evaluation in Active Surveillance Patient Population

Status unconfirmed

Conditions studied: Prostate Cancer

In brief

The goal of this observational study is to test whether the ExoDx Prostate test add value in biopsy decision making to patients with prostate cancer on an active surveillance regimen.

Key facts

Study ID

NCT05572099

Run by

Exosome Diagnostics, Inc.

People needed

750

Starts

2022-10-01

Expected to finish

2023-10-01

Last updated by the study team

2022-10-07

Who can join

Age: 45 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Male, 45+ years of age diagnosed with low-grade or favorable-intermediate prostate cancer and on an active surveillance regimen

You may not qualify if…

• Clinical symptoms of urinary tract infection at time of enrollment.
• History of invasive treatment for benign prostatic hypertrophy with in 6 months of enrollment.
• Known hepatitis or HIV
• History of concurrent renal/bladder tumors

Where it is running

• Chesapeake Urology — Towson, Maryland, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.